Article
KMT2D regulates activation, localization, and integrin expression by T-cells
3 May 2024
Abstract excerpt
Individuals with Kabuki syndrome present with immunodeficiency; however, how pathogenic variants in the gene encoding the histone-modifying enzyme lysine methyltransferase 2D (KMT2D) lead to immune alterations remain poorly understood. Following up on our prior report of KMT2D-altered integrin expression in B-cells, we performed targeted analyses of KMT2D’s influence on integrin expression in T-cells throughout...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
